RemoteA Group specialises in cardiac data analysis, remote diagnostic services and is a certified medical device manufacturer.
The global healthcare situation may at first glance appear bleak: the population is aging and healthcare resources do not increase accordingly. How can we take care of the health and well-being of the population in accordance with our shared, humane values? Fortunately, health technology offers us effective, even better solutions for sustaining our well-being and health, during the treatment of illnesses and during the rebound.
RemoteA is strongly involved in this positive development. High quality and reliable health technology solutions make it possible to take care of our fellow citizens in need of help, even more effectively than before. We believe that the healthcare revolution leads our way to improved healthcare:
We improve healthcare for patients, healthcare institutions and societies by providing a remote diagnostic service making diagnosis cheaper, better and faster. We specialise in cardiac and respiratory diagnostics.
As a result of remote monitoring and consultation services since 2002, we have developed expertise in cardiac analysis software development and we have substantial expertise in assisting the diagnosis of cardiac arrhythmia, blood pressure and sleep apnoea.
We are proud that our services have already benefited more than 160 000 healthcare customers during the last 15 years in the form of ECG, sleep apnea and ABPM consulations. We will continue to strive for improved healthcare in the future too.
RemoteA Oy has raised EUR 1.2 million in funding from the EU to develop SmartECG, an algorithm-based software product for automatically analysing ECG. Of the 104 ICT companies that applied for the funding, only four companies were chosen, with RemoteA receiving the highest scores. The SmartECG solution is made unique by its universality: SmartECG will be the first and only automatic clinical decision-making support solution to be compatible with 80% of ECG-monitoring devices, and suitable for both primary and secondary health care professionals. SmartECG will also be the first and only clinical decision making tool for GP’s when treating patients with cardiovascular disease.
With great mix of leading cardiologists, cardiac electrophysiologists, algorithm developers and business expertise, we are able to help our client organisations create more value for their end-user customers. RemoteA’s medical director is Prof. Lauri Toivonen, the former Chief Cardiologist of Helsinki University Hospital.
We have developed our remote monitoring and consultation services since 2002 and by today, we have established a widespread network of general practitioners, specialist physicians and healthcare organizations in Finland, Sweden and United Kingdom. Our Remote Diagnostics Service Platform is operated in approximately 250 health care units and leading cardiologist and respiratory consultants.
RemoteA Ltd. is a certified medical device manufacturing company and we have successfully developed and brought to market several medical devices such as an ECG holter device and our Home Polysomnography device.
As pioneers in remote diagnostics, we have so far delivered over 170 000 ECG, sleep apnea and blood pressure consultation reports. Because of our extensive background as a distance diagnostics provider we have been able to accumulate a unique database of just the right kind of data to train our algorithms with.
Our cardiac database consists of 1,5+ million hours of clinically relevant data with findings, diagnosis and treatment recommendations provided by top cardiologists.
We also have experience in seismocardiography (SCG) and have developed a smart phone application utilizing both accelerometer and gyroscope (beatscanner.com). Additionally, we have developed analytics for phonocardiography (PCG).
Ever since being founded in 2002 we have strived to enable faster and more efficient diagnosis of patients. We started off with sleep apnoea remote services, and today we are a well-established medical techonology company expanded to cardiac data analytics, versatile remote diagnostics services and medical devices. However, our story goes further back to the 1980’s where a persistent team of technical and medical professionals strived to develop executable sleep apnoea diagnosis methods.
Behind many successes we can find individuals and teams with strong vision and determination, and that is the case here too. A young physicist Pekka Tiihonen joined a team working on neurophysiological diagnostics, especially EEG-telemetry, at a hospital in the eastern part of Finland bringing technical expertise to the team. At the time, sleep apnoea analysis was quite rare and qualitative as the devices where based on expensive EEG-recorders, and therefore measuring and screening sleep apnoea was unsystematic.
The team started to develop devices suitable to use at home. The first four-channel portable device was produced by Tiihonen’s team in 1989.
The sleep briefcase was able to identify clear sleep apnea cases but it was not possible to analyse and classify them precisely. At that time the embedded device operated independently and produced respiration signal curves after recording to Windows environment, says Tiihonen. After twenty years those raw curves have been reanalyzed and several scientific articles have been published.
The so called sleep briefcase was in use the following 14 years, while the team worked simultaneously to improve the accuracy and usability of it. Venla, the first sleep apnea device aimed entirely for home use was completed in 2002. Later Pekka Tiihonen started to work on his doctoral thesis “Novel Portable Devices for Recording Sleep Apnea and Evaluating Altered Consciousness”, which was published and accepted in 2009.
As pioneers in remote diagnostics, we have thus far delivered over 170 000 ECG, sleep apnea or blood pressure consultation reports. Because of our extensive background as a distance diagnostics provider we have been able to accumulate a unique database of just the right kind of data to train our algorithms with.
We feel grateful for being a part of this history and the future of medical and technical scientific development, relentless striving for a better world. Ingenuity, responsibility and effectiveness are the values at the core of our business.
This science, heart and soul is in the RemoteA algorithm.
02/2002: Company was founded by Mr. Ossi Tiihonen to commercialize sleep apnea telemedicine platform
04/2005: Launching of the RemoteA´s ECG telemedicine consultation service in Finland
09/2007: Expansion to UK; breakeven point for consultation service
10/2009: Expansion to Sweden; database of 5000 ECG analysis reports; beginning of big data analysis and first software development
09/2013: First working prototype of SmartECG algorithm software
02/2016: Internal validation of the SmartECG algorithm; new consultation platform development; reached client base of 250 clinics
1/2017: Remote Analysis Oy was sold to Coronaria Terveyspalvelut. RemoteA continues to provide the software solution and telemedicine platform for Coronaria Analyysipalvelut Oy.
03/2017: RemoteA Oy has raised EUR 1.2 million in funding from the EU to develop SmartECG, an algorithm-based software product for automatically analysing ECG. Of the 104 ICT companies that applied for the funding, only four companies were chosen, with RemoteA receiving the highest scores
Mr Ossi Tiihonen, Managing Director
Chairman of the Board
Mr. Jarno Mäkelä, CTO
Mr. Timo Hakkarainen
Mr Lauri Toivonen
We are certified for ISO 13485 and ISO 9001 and we follow the European directive for medical devices (MDD) and the US FDA Quality System Regulations (QSR) in our quality processes. Additionally, we operate in conformance with the following standards: IEC 62304, IEC 60601-1, ISO 14971 and IEC 62366.